Exhibit 32.2

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section
906 of the Sarbanes-Oxley Act of 2002

In connection with the quarterly  report of Cellegy  Pharmaceuticals,  Inc. (the
"Company")  on Form 10-Q for the three months ended  September 30, 2003 as filed
with the United  States  Securities  and Exchange  Commission on the date hereof
(the  "Report"),  A.  Richard  Juelis,  as Vice  President,  Finance  and  Chief
Financial  Officer  of the  Company,  hereby  certifies,  pursuant  to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that:

         i.       The Report fully  complies  with the  requirements  of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         ii.      The information contained in the Report fully presents, in all
                  material  respects,  the  financial  condition  and results of
                  operations of the Company.


                               By:      /s/ A. Richard Juelis
                                        ----------------------------------------
                                        A. Richard Juelis
                                        Vice President, Finance and
                                        Chief Financial Officer
                                        Date: November 14, 2003

                                       19